Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Terminated 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Rectal Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 98pembrolizumab 87Gemcitabine 81Carboplatin 63fludarabine 62Nivolumab 57Cisplatin 54Paclitaxel 51Radiotherapy 50Docetaxel 50Rituximab 46Dexamethasone 42Lenalidomide 41Ipilimumab 38Azacitidine 35Etoposide 34Cytarabine 34Temozolomide 32Bevacizumab 32Radiation 29venetoclax 28Bortezomib 27Magnetic Resonance Spectroscopy 26Irinotecan 26atezolizumab 25Pemetrexed 25Oxaliplatin 24Capecitabine 24fludarabine phosphate 23Filgrastim 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Terminated × Tomography × Clear all
NCT02809690 2023-09-07

18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer

University of Southern California

Phase 1 Terminated
18 enrolled
Genitourinary

Prostatic Neoplasms

NCT02708511 2018-04-05

Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast Cancer

Stanford University

Phase 1 Terminated
2 enrolled
BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

NCT02112162 2016-12-08

Gene Expression and FDG PET/MRI in Evaluating Treatment Response in Patients With Locally Advanced Rectal Cancer Undergoing Chemotherapy and Radiation Therapy Before Surgery

Washington University School of Medicine

Phase 1 Terminated
2 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡